Correction: Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability
| Published in: | Journal of Cancer Research and Clinical Oncology |
|---|---|
| Main Authors: | Valerie Haller, Carina Reiff, Rainer Hamacher, Karina Kostbade, Moritz Kaths, Juergen Treckmann, Stefanie Bertram, Yasmin Zaun, Sebastian Bauer, Johanna Falkenhorst |
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-01-01
|
| Online Access: | https://doi.org/10.1007/s00432-024-06056-y |
Similar Items
Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability
by: Valerie Haller, et al.
Published: (2024-11-01)
by: Valerie Haller, et al.
Published: (2024-11-01)
SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
by: Liangying Zhang, et al.
Published: (2025-02-01)
by: Liangying Zhang, et al.
Published: (2025-02-01)
cKIT Mutations in GISTs and Other Malignancies in Thailand
by: Thongbliew Prempree, et al.
Published: (2006-03-01)
by: Thongbliew Prempree, et al.
Published: (2006-03-01)
Significance of KIT and PDGFRA mutations in gastric gist imatinib - naive surgically treated patients
by: Ebrahimi Keramatollah, et al.
Published: (2019-01-01)
by: Ebrahimi Keramatollah, et al.
Published: (2019-01-01)
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST
by: Shishan Zhou, et al.
Published: (2024-02-01)
by: Shishan Zhou, et al.
Published: (2024-02-01)
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
by: Margherita Nannini, et al.
Published: (2017-05-01)
by: Margherita Nannini, et al.
Published: (2017-05-01)
Bioinformatic analysis of KIT juxtamembrane domain mutations in Syrian GIST patients: jigsaw puzzle completed
by: Nour Pharaon, et al.
Published: (2023-08-01)
by: Nour Pharaon, et al.
Published: (2023-08-01)
SHP2 inhibition and adjuvant therapy synergistically target KIT‐mutant GISTs via ERK1/2‐regulated GSK3β/cyclin D1 pathway
by: Chunxiao He, et al.
Published: (2025-02-01)
by: Chunxiao He, et al.
Published: (2025-02-01)
Lymph Node Staging in Perihilar Cholangiocarcinoma: The Key to the Big Picture
by: Nina A. Rogacka, et al.
Published: (2023-06-01)
by: Nina A. Rogacka, et al.
Published: (2023-06-01)
Mutational Analysis of <i>c-KIT</i> and <i>PDGFRA</i> in Canine Gastrointestinal Stromal Tumors (GISTs)
by: Maria Morini, et al.
Published: (2022-07-01)
by: Maria Morini, et al.
Published: (2022-07-01)
KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST.
by: Olaf Karl Klinke, et al.
Published: (2015-01-01)
by: Olaf Karl Klinke, et al.
Published: (2015-01-01)
GIST and Ghrelin: To Be or Not to Be?
by: Irene Alexandra Spiridon, et al.
Published: (2021-07-01)
by: Irene Alexandra Spiridon, et al.
Published: (2021-07-01)
Management of GIST
by: W Wanitsuwan, et al.
Published: (2007-10-01)
by: W Wanitsuwan, et al.
Published: (2007-10-01)
GIST apendicular
by: Ángela María Calle, et al.
Published: (2015-01-01)
by: Ángela María Calle, et al.
Published: (2015-01-01)
Correction: miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT
by: Yu Wang, et al.
Published: (2023-12-01)
by: Yu Wang, et al.
Published: (2023-12-01)
Aging Kit mutant mice develop cardiomyopathy.
by: Lei Ye, et al.
Published: (2012-01-01)
by: Lei Ye, et al.
Published: (2012-01-01)
KIT exon 11 and PDGFRA exon 18 gene mutations in gastric GIST: proposal of a short panel for predicting therapeutic response
by: Denise Barcelos, et al.
Published: (2018-11-01)
by: Denise Barcelos, et al.
Published: (2018-11-01)
Gastrointestinal Stromal Tumours (GISTs) with KRAS Mutation: A Rare but Important Subset of GISTs
by: Dorinda Mullen, et al.
Published: (2023-01-01)
by: Dorinda Mullen, et al.
Published: (2023-01-01)
The Regulation of SPRY4 Intronic Transcript 1 (SPRY4-IT1) on KIT Signaling and Imatinib Resistance of Gastrointestinal Stromal Tumor (GIST) Cells
by: Yuanyuan Yu, et al.
Published: (2024-08-01)
by: Yuanyuan Yu, et al.
Published: (2024-08-01)
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report
by: Elisa Tassinari, et al.
Published: (2023-12-01)
by: Elisa Tassinari, et al.
Published: (2023-12-01)
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents
by: Riccardo Ricci, et al.
Published: (2019-01-01)
by: Riccardo Ricci, et al.
Published: (2019-01-01)
GIST: gastrointestinal stromal tumors.
by: Sara Uria, et al.
Published: (2012-06-01)
by: Sara Uria, et al.
Published: (2012-06-01)
„Tumorile GIST gastrice gigante”.
by: Mircea Cernat, et al.
Published: (2019-11-01)
by: Mircea Cernat, et al.
Published: (2019-11-01)
GASTROINTESTINAL STROMAL TUMOR (GIST)
by: Luigi eTornillo
Published: (2014-11-01)
by: Luigi eTornillo
Published: (2014-11-01)
Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible?
by: Kim Ki-Han, et al.
Published: (2012-10-01)
by: Kim Ki-Han, et al.
Published: (2012-10-01)
Data on quantification of signaling pathways activated by KIT and PDGFRA mutants
by: Christelle Bahlawane, et al.
Published: (2016-12-01)
by: Christelle Bahlawane, et al.
Published: (2016-12-01)
Novas perspectivas no tratamento do GIST
by: Marcus Valadão, et al.
Published: (2006-12-01)
by: Marcus Valadão, et al.
Published: (2006-12-01)
GIST Gástrico - Experiência do INCA
by: Marcus Valadão, et al.
Published: (2004-06-01)
by: Marcus Valadão, et al.
Published: (2004-06-01)
Gastrointestinal stromaal tumor (GIST) in the jejunum
by: Alessandra Canelo, et al.
Published: (2023-01-01)
by: Alessandra Canelo, et al.
Published: (2023-01-01)
Tumor del estroma gastrointestinal (GIST).
by: Andrea Bautista R., et al.
Published: (2021-09-01)
by: Andrea Bautista R., et al.
Published: (2021-09-01)
Presentation of GIST as jejuno-jejunal intussusception
by: Anil Kumar, et al.
Published: (2018-03-01)
by: Anil Kumar, et al.
Published: (2018-03-01)
Tumor del estroma gastrointestinal GIST
by: Jorge Jiménez Barahona, et al.
Published: (2025-05-01)
by: Jorge Jiménez Barahona, et al.
Published: (2025-05-01)
When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis
by: Desilva Keshani, et al.
Published: (2009-01-01)
by: Desilva Keshani, et al.
Published: (2009-01-01)
Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.
by: Jean-Baptiste Bachet, et al.
Published: (2013-01-01)
by: Jean-Baptiste Bachet, et al.
Published: (2013-01-01)
A Canine <i>c-kit</i> Novel Mutation Isolated from a Gastrointestinal Stromal Tumor (GIST) Retains the Ability to Form Dimers but Lacks Autophosphorylation
by: Kei Shimakawa, et al.
Published: (2025-05-01)
by: Kei Shimakawa, et al.
Published: (2025-05-01)
All-<it>trans </it>retinoic acid inhibits KIT activity and induces apoptosis in gastrointestinal stromal tumor GIST-T1 cell line by affecting on the expression of survivin and Bax protein
by: Taguchi Takahiro, et al.
Published: (2010-12-01)
by: Taguchi Takahiro, et al.
Published: (2010-12-01)
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma
by: Yao Zhan, et al.
Published: (2024-04-01)
by: Yao Zhan, et al.
Published: (2024-04-01)
GASTROINTESTINAL STROMAL TUMORS (GIST): DIAGNOSIS AND TREATMENT
by: N. I. Bogomolov, et al.
Published: (2017-11-01)
by: N. I. Bogomolov, et al.
Published: (2017-11-01)
Advances in the management of gastrointestinal stromal tumors (GISTs)
by: Monika Dudzisz-Śledź, et al.
Published: (2020-12-01)
by: Monika Dudzisz-Śledź, et al.
Published: (2020-12-01)
Video capsule enteroscopy in the diagnosis of GIST of the ileum
by: A. T. Kortieva, et al.
Published: (2023-07-01)
by: A. T. Kortieva, et al.
Published: (2023-07-01)
Similar Items
-
Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability
by: Valerie Haller, et al.
Published: (2024-11-01) -
SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
by: Liangying Zhang, et al.
Published: (2025-02-01) -
cKIT Mutations in GISTs and Other Malignancies in Thailand
by: Thongbliew Prempree, et al.
Published: (2006-03-01) -
Significance of KIT and PDGFRA mutations in gastric gist imatinib - naive surgically treated patients
by: Ebrahimi Keramatollah, et al.
Published: (2019-01-01) -
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST
by: Shishan Zhou, et al.
Published: (2024-02-01)
